会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Sample handling system
    • 样品处理系统
    • US06290907B1
    • 2001-09-18
    • US09150931
    • 1998-09-10
    • Katsushi TakahashiMikio KomataToshiyuki Ikeda
    • Katsushi TakahashiMikio KomataToshiyuki Ikeda
    • G01N3502
    • G01N35/026G01N35/00712G01N35/0092G01N2035/00326G01N2035/00752Y10T436/108331Y10T436/113332Y10T436/114165Y10T436/115831
    • A sample handling system comprising: a transportation line including a combination of plural partitive line units; and a plurality of handling units, wherein each of the plural partitive line units and each of the plurality of handling units form a pair, and each handling unit is installed removably from its corresponding partitive line unit. Each handling unit transmits inoperative information to the transportation line when it becomes inoperative. The transportation line transmits this inoperative information to the central controller. The central controller monitors handling units at which the sample rack can stop over. The sample rack avoids stopover at the inoperative handling unit, but is allowed to advance to the subsequent handling unit passing through the partitive line unit which makes a pair with the inoperative handling unit.
    • 一种样本处理系统,包括:包括多个分支线单元的组合的输送线; 以及多个处理单元,其中所述多个分立线单元和所述多个处理单元中的每一个形成一对,并且每个处理单元可拆卸地安装在其相应的部分线单元上。 每个处理单元在不工作时将不起作用的信息传送到运输线。 运输线将此无效信息传送给中央控制器。 中央控制器监控样品架可以停止的处理单元。 样品架避免在不操作处理单元中停留,但允许前进到后续的处理单元通过与不操作处理单元成对的部分单元。
    • 4. 发明授权
    • Benzene derivatives
    • 苯衍生物
    • US5808144A
    • 1998-09-15
    • US875284
    • 1997-07-23
    • Masaichi HasegawaTakumi TakeyasuNaoki TsuchiyaNaoki HaseKatsushi TakahashiTakashi Kamimura
    • Masaichi HasegawaTakumi TakeyasuNaoki TsuchiyaNaoki HaseKatsushi TakahashiTakashi Kamimura
    • C07C235/38C07C229/00C07C321/00
    • C07C235/38C07C2101/14
    • Novel benzene derivatives of the formula (I) shown below, pharmacological salts thereof, pharmacological solvates of the above-mentioned benzene derivatives and salts, pharmaceutical compositions including, as active ingredients, the above-mentioned compounds, and especially, prophylactic or therapeutic medicines for allergic diseases. ##STR1## wherein R.sup.1 =H, C.sub.1 -C.sub.12 cyclic or straight or branched chain alkyl group (which may be substituted by one or more C.sub.6 -C.sub.10 aryloxy groups), C.sub.7 -C.sub.12 aralkyl group (of which the aryl group may be substituted one or more of halogen, methyl and methoxy, or C.sub.3 -C.sub.10 alkenyl which may be substituted by one or more phenyl groups; A=O, S or CH.sub.2 group, B=CO or CZ.sub.2 CO group (Z=H or F), R.sup.2 =H or C.sub.1 -C.sub.4 alkyl group, X=halogen or methyl group, and Y=H, NO.sub.2 or CN group.
    • PCT No.PCT / JP96 / 03456 Sec。 371日期1997年7月23日 102(e)日期1997年7月23日PCT提交1995年11月27日PCT公布。 第WO97 / 19910号公报 日期:1997年5月6日下述式(I)的新型苯衍生物,其药理学盐,上述苯衍生物和盐的药理学溶剂化物,作为活性成分的上述化合物,特别是预防性 或用于过敏性疾病的治疗药物。 (I)其中R1 = H,C1-C12环状或直链或支链烷基(其可被一个或多个C 6 -C 10芳氧基取代),C 7 -C 12芳烷基(其芳基可以 取代一个或多个卤素,甲基和甲氧基,或可被一个或多个苯基取代的C 3 -C 10链烯基; A = O,S或CH 2基团,B = CO或CZ 2 CO基团(Z = H或F) ,R2 = H或C1-C4烷基,X =卤素或甲基,Y = H,NO2或CN基团。